keyword
MENU ▼
Read by QxMD icon Read
search

Anipryl

keyword
https://www.readbyqxmd.com/read/19753696/a-noncomparative-open-label-study-evaluating-the-effect-of-selegiline-hydrochloride-in-a-clinical-setting
#1
S Campbell, A Trettien, B Kozan
Six hundred forty-one dogs with clinical signs consistent with canine cognitive dysfunction syndrome (CDS) were treated orally with selegiline hydrochloride at 0.5 to 1.0 mg/kg once daily for 60 days. Response to selegiline treatment on days 30 and 60 were similar. On day 60, 77.2% of dogs showed an overall improvement; response to treatment by clinical sign ranged from 67.8% (activity or sleep/wake cycle) to 77.8% (disorientation and interaction with family members). All dogs enrolled in the study were monitored for possible adverse events; diarrhea (4...
2001: Veterinary Therapeutics: Research in Applied Veterinary Medicine
https://www.readbyqxmd.com/read/12086427/cushing-s-syndrome-with-concurrent-diabetes-mellitus-in-a-rhesus-monkey
#2
Andrew C. Wilkinson, Linda D. Harris, George A. Saviolakis, Dale G. Martin
Cushing's syndrome is the clinical expression of the overproduction of glucocorticoids and is well recognized in both human and veterinary medicine. Spontaneous diabetes mellitus is well known in Macaca spp., however the occurrence of hyperadrenocorticism and diabetes mellitus concurrently in macaques has not been reported previously. This unusual case presents a rare opportunity to examine the relationships between two important endocrine diseases in a nonhuman primate. A male, 14-year-old rhesus macaque (Macaca mulatta) was diagnosed with hyperadrenocorticism and concurrent diabetes mellitus...
May 1999: Contemporary Topics in Laboratory Animal Science
https://www.readbyqxmd.com/read/10449217/medical-treatment-of-pituitary-dependent-hyperadrenocorticism-in-dogs-should-l-deprenyl-anipryl-ever-be-used
#3
EDITORIAL
M E Peterson
No abstract text is available yet for this article.
July 1999: Journal of Veterinary Internal Medicine
https://www.readbyqxmd.com/read/9076907/management-of-canine-pituitary-dependent-hyperadrenocorticism-with-l-deprenyl-anipryl
#4
REVIEW
D S Bruyette, W W Ruehl, T Entriken, D Griffin, L Darling
In this chapter we have discussed the pathogenesis of canine PDH focusing on its relationship to aging, dopamine deficiency, and neurodegenerative disease. We have outlined the successful management of canine PDH patients with l-deprenyl, a selective MAO-B inhibitor. Treatment with l-deprenyl results in clinical and endocrinologic improvement (partial to complete) in approximately 83% of dogs, with improvement noted within the first 1 to 2 months of therapy. The safety profile of l-deprenyl is excellent, especially in light of the fact that the majority of patients are elderly...
March 1997: Veterinary Clinics of North America. Small Animal Practice
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"